research Alopecia Areata After Mogamulizumab Treatment
Mogamulizumab can cause hair loss and skin rashes.
Search
forLearn
0 / 0 results — no results
Research
5 / 13 results
research Alopecia Areata-Like Presentations With Mogamulizumab Therapy
Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.
research An Occurrence of Eosinophilic Folliculitis and Alopecia Associated with a Sustained Complete Response to Mogamulizumab in Sézary Syndrome: A Case Report
Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.
research Issue Information
research Cutaneous Manifestations and Considerations in COVID-19 Pandemic: A Systematic Review
COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.
Community Join
0 / 0 results — no results